Market Research Report
Asia-Pacific Respiratory Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
|Asia-Pacific Respiratory Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)|
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 70 Pages
Delivery time: 2-3 business days
Asia-Pacific is the fastest-growing market at a global level, owing to the increasing purchasing power of patients in countries, such as India and China. The demand for better healthcare in the Asia-Pacific region is due to the increasing respiratory diseases and the growing aging population. Growing economic growth and urbanization of Asian countries, initiatives taken by the local governments, such as healthcare awareness programs and collaborations with the NGO's to create healthcare awareness, are contributing toward the change in demand patterns, which are driving the respiratory monitoring market in the Asia-Pacific region. The other factors also include the rise in the number of smokers, high prevalence of respiratory diseases, and the growing pollution levels and development of advanced technologies. On the other hand, the high cost of devices and the unfavourable regulatory reforms are likely to impede the market growth for respiratory monitoring market in the Asia-Pacific region.
The market is segmented on the basis of the type of device and geography. Type of device is further divided into Spirometers, Peak Flow Meters, Sleep Test Devices, Gas Analyzers, Pulse Oximeters, and Capnographs.
The spirometer segment is anticipated to hold a significant market share during the forecast period, owing to the increasing prevalence of respiratory diseases. There are various types of spirometers, such as desktop, hand-held, and tabletop spirometers. Clinics and hospitals are extensively using tabletop spirometers, and home care settings are using a handheld spirometer, owing to their convenience and accessibility. The Asia-Pacific region is home for a large heterogeneous population whose respiratory health is influenced by the social, economic, and environmental factors. Despite this variability, most of the prevalent causes of respiratory mortality and morbidity are air pollution, infection, and tobacco smoking. Hence, these factors are expected to positively impact the market growth.
The market comprises of major market players, who are focusing on R&D, in order to form the stable and safe formulation. The market has been noticing technological developments on a large scale, for the past couple of years. Some of the market players are Medtronic, Draegerwerk, GE Healthcare, Philips, Resmed, Siemens Healthcare, Teijin Pharma, etc.